SUPN - Supernus Pharmaceuticals Inc Revenue Breakdown

Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Peers: INDV ALKS LNTH NBIX AMRX KNSA ACAD TLX BIIB VRTX

| Held by: IJR VTI IWM VB VBR VXF SPSM IWN IJT VTWO

Scroll to Statements

Index	RUT
Market Cap	2.70B
Enterprise Value	2.37B
Income	-109.89M
Sales	830.44M
Book/sh	17.73
Cash/sh	6.40
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	778
IPO	May 01, 2012

P/E	-
Forward P/E	9.97
PEG	0.54
P/S	3.25
P/B	2.62
P/C	7.25
P/FCF	143.54
EV/EBITDA	63.04
EV/Sales	2.85
Quick Ratio	1.84
Current Ratio	2.08
Debt/Eq	0.04
LT Debt/Eq	0.03
Option/Short	Yes / Yes

EPS (ttm)	-1.91
EPS next Y	4.66
EPS next Q	0.68
EPS this Y	-13.44%
EPS next Y	66.25%
EPS next 5Y	18.63%
EPS past 3/5Y	- -
Sales past 3/5Y	2.52% 6.68%
EPS Y/Y TTM	-264.42%
Sales Y/Y TTM	24.85%
EPS Q/Q	-353.07%
Sales Q/Q	32.40%
Earnings	Aug 03 BMO
EPS/Sales Surpr.	24.52% 6.70%

Insider Own	6.20%
Insider Trans	-4.80%
Inst Own	99.44%
Inst Trans	-0.54%
ROA	-7.82%
ROE	-10.49%
ROIC	-10.36%
Gross Margin	75.83%
Oper. Margin	-7.73%
Profit Margin	-13.23%
SMA20	-1.07%
SMA50	0.50%
SMA200	-5.22%
Trades

Shs Outstand	58.16M
Shs Float	54.44M
Short Float	8.91%
Short Ratio	5.63
Short Interest	4.85M
52W High	59.68 -22.25%
52W Low	36.46 27.26%
Volatility	7.61% 4.57%
ATR (14)	2.35
RSI (14)	49.61
Beta	0.55
Rel Volume	2.18
Avg Volume	861.06K
Volume	450,177

Perf Week	-0.37%
Perf Month	-3.21%
Perf Quarter	-5.67%
Perf Half Y	-4.13%
Perf YTD	-6.64%
Perf Year	23.63%
Perf 3Y	44.19%
Perf 5Y	74.50%
Perf 10Y	100.78%
Recom	1.50
Target Price	62.50
Prev Close	43.25
Price	46.40
Change	7.28%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)